March 10th, 2020
In March 2020, a class-action lawsuit was filed against Germ-X for allegedly misleadingly advertising that Germ-X hand sanitizers prevent and reduce infections from the flu and other viruses – including coronavirus – when, according to plaintiffs, there are no reliable studies to support such claims. (David et al v. Vi-Jon, Inc. d/b/a Germ-X, 20-cv-424, S.D.
February 18th, 2020
In February 2020, a class-action lawsuit was filed against Vi-Jon, Inc. for allegedly misleadingly marketing that Germ-X hand sanitizers will prevent and reduce the flu and other viruses when, according to the complaint, the company does not have adequate scientific studies to support such claims. (Sibley et al v. Vi-Jon, Inc., Case No. 20-cv-951, N.D.
January 16th, 2021
The pandemic has also triggered lawsuits over privacy issues with some video conferencing apps, and more.
December 29th, 2020
A class-action lawsuit was filed against Vi-Jon for allegedly falsely marketing that store-brand hand sanitizers – including Equate, Up & Up, Walgreens, and Germ-X – “Kill[] 99.99% of germs” when, according to the complaint, the products are not effective against certain viruses, bacteria, and other disease-causing organisms. The complaint was originally filed in September 2020
August 10th, 2020
In July 2020, a class-action lawsuit was filed against Vi-Jon, Inc. for allegedly falsely advertising that germ-X and several store-brand hand sanitizers – including CVS Health, equate (Walmart), and Walgreens – kill 99.99% of germs when, according to plaintiffs, the products are not effective against several organisms that cause diseases, such as the norovirus and
April 9th, 2020
The bottom line: Only FDA-approved drugs can be marketed to prevent disease.
